Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Oxford Cannabinoid Technologies

Oxford Cannabinoid Technologies
2017 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$10.6M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of cannabinoid based compounds and therapies created to provide more evidence for the effects of cannabinoids in a number of diseases. The company's novel cannabinoid-based therapies have range of potential medical applications including Inflammatory Disease, Oncology,Neurological Disorders, Pain Management, enabling doctors to get cannabinoid-based medication for improving the quality of life for millions of patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 71-75 Shelton Street
  • Covent Garden
  • London WC2H 9JQ
  • England, United Kingdom

+44 01865 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Oxford Cannabinoid Technologies’s full profile, request a free trial.

Oxford Cannabinoid Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 28-Feb-2018 $10.6M 0000 Completed Product Development
1. Early Stage VC 15-Mar-2017 000.00 000.00 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Oxford Cannabinoid Technologies Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Connecticut Pharmaceutical Solutions Private Equity-Backed Portland, CT 000000000000
0000000000 0000000 Corporation Moncton, Canada 000 000000000000
To view this company’s complete list of competitors, request access »

Oxford Cannabinoid Technologies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Casa Verde Capital Venture Capital Minority 000 0000 000000 0
Imperial Brands Corporation Minority 000 0000 000000 0
Patrick Stewart Angel (individual) Minority 000 0000 000000 0
Kingsley Capital Partners PE/Buyout Minority 000 0000 000000 0

Oxford Cannabinoid Technologies Executive Team (4)

Name Title Board
Seat
Contact
Info
Jutta Roth Ph.D Chief Scientific Officer
Eugenia Shostak Financial Controller
John Lucas JD Chief Commercial Officer
Patrick Stewart Advisory Board Member

Oxford Cannabinoid Technologies Board Members (4)

Name Representing Role Since Contact
Info
Gavin Sathianathan Kingsley Capital Partners Non-Executive Director 000 0000
Hee-Dong Kim Kingsley Capital Partners Non-Executive Director 000 0000
Karan Wadhera Self Non-Executive Director 000 0000
Neil Mahapatra Oxford Cannabinoid Technologies Founder & Chairman 000 0000